Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors

BACKGROUND AND AIMS: Analysed using classical frequentist hypothesis testing with alpha set to 0.05, the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) did not find enough evidence to reject the hypothesis of no difference in neuropsychiatric adverse events (NPSAEs) attributa...

Descripción completa

Detalles Bibliográficos
Autores principales: Beard, Emma, Jackson, Sarah E., Anthenelli, Robert M., Benowitz, Neal L., Aubin, Lisa St., McRae, Thomas, Lawrence, David, Russ, Cristina, Krishen, Alok, Evins, A. Eden, West, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612131/
https://www.ncbi.nlm.nih.gov/pubmed/33885203
http://dx.doi.org/10.1111/add.15440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612131/
https://www.ncbi.nlm.nih.gov/pubmed/33885203
http://dx.doi.org/10.1111/add.15440

Ejemplares similares